Annual CFO
$183.50 M
+$94.32 M+105.76%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual cash flow from operations is currently $183.50 million, with the most recent change of +$94.32 million (+105.76%) on 31 December 2023. During the last 3 years, it has risen by +$126.24 million (+220.44%). AMPH annual CFO is now at all-time high.AMPH Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$59.96 M
-$9.15 M-13.24%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly cash flow from operations is currently $59.96 million, with the most recent change of -$9.15 million (-13.24%) on 30 September 2024. Over the past year, it has dropped by -$4.37 million (-6.80%). AMPH quarterly CFO is now -13.24% below its all-time high of $69.11 million, reached on 30 June 2024.AMPH Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$208.23 M
-$4.37 M-2.06%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM cash flow from operations is currently $208.23 million, with the most recent change of -$4.37 million (-2.06%) on 30 September 2024. Over the past year, it has increased by +$33.36 million (+19.08%). AMPH TTM CFO is now -2.06% below its all-time high of $212.60 million, reached on 30 June 2024.AMPH TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +105.8% | -6.8% | +19.1% |
| 3 y3 years | +220.4% | +2234.1% | +179.7% |
| 5 y5 years | +380.5% | +599.6% | +356.4% |
AMPH Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +220.4% | -13.2% | +2234.1% | -2.1% | +179.7% |
| 5 y | 5 years | at high | +380.5% | -13.2% | +599.6% | -2.1% | +725.8% |
| alltime | all time | at high | >+9999.0% | -13.2% | +599.6% | -2.1% | >+9999.0% |
Amphastar Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $59.96 M(-13.2%) | $208.23 M(-2.1%) |
| June 2024 | - | $69.11 M(+25.0%) | $212.60 M(+7.1%) |
| Mar 2024 | - | $55.29 M(+131.7%) | $198.41 M(+8.1%) |
| Dec 2023 | $183.50 M(+105.8%) | $23.86 M(-62.9%) | $183.50 M(+4.9%) |
| Sept 2023 | - | $64.33 M(+17.1%) | $174.87 M(+33.6%) |
| June 2023 | - | $54.92 M(+36.0%) | $130.91 M(+66.1%) |
| Mar 2023 | - | $40.38 M(+165.2%) | $78.80 M(-11.6%) |
| Dec 2022 | $89.18 M(-9.0%) | $15.23 M(-25.3%) | $89.18 M(-22.0%) |
| Sept 2022 | - | $20.38 M(+623.8%) | $114.40 M(+18.4%) |
| June 2022 | - | $2.81 M(-94.5%) | $96.59 M(-23.3%) |
| Mar 2022 | - | $50.77 M(+25.5%) | $125.93 M(+28.5%) |
| Dec 2021 | $97.99 M(+71.1%) | $40.44 M(+1474.2%) | $97.99 M(+31.6%) |
| Sept 2021 | - | $2.57 M(-92.0%) | $74.45 M(-7.7%) |
| June 2021 | - | $32.16 M(+40.9%) | $80.68 M(+2.6%) |
| Mar 2021 | - | $22.82 M(+35.1%) | $78.61 M(+37.3%) |
| Dec 2020 | $57.27 M(+37.1%) | $16.89 M(+91.8%) | $57.27 M(+24.4%) |
| Sept 2020 | - | $8.81 M(-70.7%) | $46.02 M(+82.5%) |
| June 2020 | - | $30.09 M(+1937.2%) | $25.21 M(-46.2%) |
| Mar 2020 | - | $1.48 M(-73.9%) | $46.85 M(+12.2%) |
| Dec 2019 | $41.76 M(+9.4%) | $5.65 M(-147.1%) | $41.76 M(-8.5%) |
| Sept 2019 | - | -$12.00 M(-123.2%) | $45.63 M(-37.8%) |
| June 2019 | - | $51.72 M(-1532.8%) | $73.41 M(+180.0%) |
| Mar 2019 | - | -$3.61 M(-137.9%) | $26.22 M(-31.3%) |
| Dec 2018 | $38.19 M | $9.52 M(-39.7%) | $38.19 M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $15.78 M(+248.1%) | $38.44 M(+53.0%) |
| June 2018 | - | $4.53 M(-45.8%) | $25.13 M(-0.2%) |
| Mar 2018 | - | $8.36 M(-14.4%) | $25.17 M(-35.8%) |
| Dec 2017 | $39.21 M(+1.7%) | $9.77 M(+295.0%) | $39.21 M(-9.8%) |
| Sept 2017 | - | $2.47 M(-46.0%) | $43.45 M(+2.8%) |
| June 2017 | - | $4.57 M(-79.6%) | $42.28 M(-10.1%) |
| Mar 2017 | - | $22.40 M(+59.9%) | $47.03 M(+22.0%) |
| Dec 2016 | $38.56 M(+261.0%) | $14.01 M(+979.0%) | $38.56 M(+38.5%) |
| Sept 2016 | - | $1.30 M(-86.1%) | $27.84 M(-7.5%) |
| June 2016 | - | $9.33 M(-33.1%) | $30.10 M(+29.3%) |
| Mar 2016 | - | $13.93 M(+323.8%) | $23.27 M(+117.9%) |
| Dec 2015 | $10.68 M(-49.3%) | $3.29 M(-7.5%) | $10.68 M(-45.8%) |
| Sept 2015 | - | $3.55 M(+41.9%) | $19.72 M(-33.8%) |
| June 2015 | - | $2.50 M(+87.1%) | $29.79 M(+5.6%) |
| Mar 2015 | - | $1.34 M(-89.1%) | $28.23 M(+34.1%) |
| Dec 2014 | $21.05 M(-32.2%) | $12.32 M(-9.6%) | $21.05 M(+22.1%) |
| Sept 2014 | - | $13.63 M(+1359.3%) | $17.24 M(+299.1%) |
| June 2014 | - | $934.00 K(-116.0%) | $4.32 M(-81.8%) |
| Mar 2014 | - | -$5.83 M(-168.6%) | $23.68 M(-23.7%) |
| Dec 2013 | $31.04 M(-1981.3%) | $8.51 M(+1100.6%) | $31.04 M(+37.8%) |
| Sept 2013 | - | $709.00 K(-96.5%) | $22.53 M(+3.2%) |
| June 2013 | - | $20.29 M(+1229.0%) | $21.82 M(+1329.0%) |
| Mar 2013 | - | $1.53 M | $1.53 M |
| Dec 2012 | -$1.65 M(-108.6%) | - | - |
| Dec 2011 | $19.10 M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual CFO year-on-year change?
- What is Amphastar Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly CFO year-on-year change?
- What is Amphastar Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM CFO year-on-year change?
What is Amphastar Pharmaceuticals annual cash flow from operations?
The current annual CFO of AMPH is $183.50 M
What is the all time high annual CFO for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual cash flow from operations is $183.50 M
What is Amphastar Pharmaceuticals annual CFO year-on-year change?
Over the past year, AMPH annual cash flow from operations has changed by +$94.32 M (+105.76%)
What is Amphastar Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AMPH is $59.96 M
What is the all time high quarterly CFO for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly cash flow from operations is $69.11 M
What is Amphastar Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, AMPH quarterly cash flow from operations has changed by -$4.37 M (-6.80%)
What is Amphastar Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AMPH is $208.23 M
What is the all time high TTM CFO for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM cash flow from operations is $212.60 M
What is Amphastar Pharmaceuticals TTM CFO year-on-year change?
Over the past year, AMPH TTM cash flow from operations has changed by +$33.36 M (+19.08%)